لابراتوارهای سینادارو
دسینا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Cash Flow
AGM
Interim
2026/06/10 Fiscal Year 2026/03/2012 Month / Audited | 2026/06/09 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 13.452 Trillion | 13.452 Trillion | |
Income Taxes Paid | -1.745 Trillion | -1.745 Trillion | |
Net Cash Flow from Operating Activities | 11.706 Trillion | 11.706 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 9.733 Billion | 9.733 Billion | |
Purchases of Property, Plant and Equipment | -1.413 Trillion | -1.413 Trillion | |
Purchases of Intangible Assets | -105 Million | -105 Million | |
Proceeds from Sale of Short-Term Investments | 3.8 Trillion | 3.8 Trillion | |
Cash Paid to Acquire Short-Term Investments | -6.828 Trillion | -6.828 Trillion | |
Dividends Received | 1.751 Billion | 1.751 Billion | |
Cash Received from Income on Other Investments | 143.813 Billion | 143.813 Billion | |
Net Cash Flow from Investing Activities | -4.286 Trillion | -4.286 Trillion | |
Net Cash Flow before Financing Activities | 7.42 Trillion | 7.42 Trillion | |
Proceeds from Sale of Treasury Shares | 25.713 Billion | 25.713 Billion | |
Purchases of Treasury Shares | -65.142 Billion | -65.142 Billion | |
Cash Received from Borrowings | 7.267 Trillion | 7.267 Trillion | |
Repayments of Borrowings (Principal) | -4.364 Trillion | -4.364 Trillion | |
Interest Paid on Borrowings | -611.793 Billion | -611.793 Billion | |
Dividends Paid | -7.845 Trillion | -7.845 Trillion | |
Net Cash Flow from Financing Activities | -5.593 Trillion | -5.593 Trillion | |
Net Increase (Decrease) in Cash | 1.827 Trillion | 1.827 Trillion | |
Cash at Beginning of Period | 2.072 Trillion | 2.072 Trillion | |
Effect of Exchange Rate Changes | 63.074 Billion | 63.074 Billion | |
Cash at End of Period | 2.135 Trillion | 2.147 Trillion |